Atjaunināt sīkdatņu piekrišanu

E-grāmata: Renal Pharmacotherapy: Dosage Adjustment of Medications Eliminated by the Kidneys

, , , , ,
  • Formāts: EPUB+DRM
  • Izdošanas datums: 24-Sep-2021
  • Izdevniecība: Springer Nature Switzerland AG
  • Valoda: eng
  • ISBN-13: 9783030586508
Citas grāmatas par šo tēmu:
  • Formāts - EPUB+DRM
  • Cena: 71,37 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
Renal Pharmacotherapy: Dosage Adjustment of Medications Eliminated by the KidneysPalielināt
  • Formāts: EPUB+DRM
  • Izdošanas datums: 24-Sep-2021
  • Izdevniecība: Springer Nature Switzerland AG
  • Valoda: eng
  • ISBN-13: 9783030586508
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.


To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function.  Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications.

This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys.  Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types.

Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.



A: Acamprosate to Aztreonam

B: Bacitracin to Butorphanol

C: Capecitabine to Cycloserine

D: Dabigatran to Dyphylline

E: Edetate Calcium Disodium to Exenatide

F: Famciclovir to Fosfomycin

G: Gabapentin to Glyburide

H: Hetastarch to Hydroxyurea

I: Ibandronate to Itraconazole

K: Kanamycin to Ketorolac

L: Lacosamide to Lurasidone

M: Magnesium Citrate to Mycophenolate Mofetil

N: Nabumetone to Norfloxacin

O: Ofloxacin to Oxcarbazepine

P: Paliperidone to Pyridostigmine

Q: Quinapril to Quinine

R: Ramipril to Ruxolitinib

S: Salsalate to Sunitinib

T: Tadalafil to Trospium

V: Valacyclovir to Voriconazole

Z: Zalcitabine to Zonisamide

Proprietary Name Index

Larry K. Golightly, PharmD





Clinical Research Pharmacist





University of Colorado Hospital





Aurora, CO 80045





larry.golightly@uchealth.org





 





Isaac Teitelbaum, MD, FACP





Professor of Medicine





Renal Medicine and Hypertension Section, Division of General Internal Medicine





University of Colorado School of Medicine and





Director, Home Dialysis Program





University of Colorado Hospital





Aurora, CO 80045





isaac.teitelbaum@cuanschutz.edu





 





Bonita A. Simendinger, PharmD, BCPS





P&T Formulary Compliance Specialist





University of Colorado Hospital





Aurora, CO 80045





bonita.simendinger@uchealth.org





 





Tyree H. Kiser, PharmD, BCPS, FCCP, FCCM





Professor, Department of Clinical Pharmacy





University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and





Critical Care Pharmacy Specialist





University of Colorado Hospital





Aurora, CO 80045





ty.kiser@cuanschutz.edu





 





Gerard R. Barber, RPh, MPH, FASHP





Clinical Assistant Professor, Department of Clinical Pharmacy





University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences





Aurora, CO 80045





gerard.barber@cuanschutz.edu





 





Nancy M. Stolpman, PharmD, PhD





Associate Clinical Professor





University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and





Lead Director of Pharmacy





UCHealth





Aurora, CO 80045





nancy.stolpman@uchealth.org
Biežāk uzdotie jautājumi par e-grāmatām Biežāk uzdotie jautājumi par e-grāmatām
Permanent link: https://www.kriso.lv/db/97830305865086e.html